TechnoMark News

The global monocyte activation test market is witnessing continuous advancements in test offerings and extensive growth in the product portfolio of major as well as local manufacturers. The growth of the global monocyte activation test market is attributed to increasing number of pharmaceutical and biotechnology industries globally, rising research and development, increased investments and surge in new drug approval activities. Additionally, a proposed ban on animal tests has resulted in reducing the use of the rabbit for pyrogen test. This is one of the significant factors that is driving the growth of monocyte activation tests globally. Increase in public and regulatory concerns about product safety further support the market growth. Major Key Players of the Monocyte Activation Test Market are: Merck, Thermo Fisher Scientific, Becton, Dickinson and Company, Sanquin, Charles River Laboratories International, Inc., Microcoat Biotechnologie GmbH, SOLVIAS AG and Lonza Group among others...

Growing prevalence rates of Alzheimers disease globally and rising geriatric population worldwide is anticipated to fuel the growth of Alzheimers drugs market. With the globally increasing ageing population, the number of patients suffering from Alzheimers disease is projected to grow during the forecast period. According to the World Health Organization (WHO) between the years 2015 and 2050, the proportion of the worlds population over 60 years will nearly double from 12% to 22%. It is estimated that dementia affects 46.8 million people worldwide with an estimated cost of USD 818 billion. Alzheimers disease is the most common cause of dementia, with 9.9 million people newly diagnosed with dementia each year. Unfortunately there is no cure for Alzheimers, which has become one of the greatest public health challenges globally. These factors are expected fuel the Alzheimers Drugs Market in the forecast period. Current treatments focus on delaying the onset of the disease and on alleviati...

The continual growth of the biopharmaceutical industries has presented a bright prospect for the growth of global membrane chromatography market. Other factors such as benefits of using membrane chromatography as an alternative to conventional chromatography and increasing R&D expenditure are anticipated to contribute substantially to the growth of the global membrane chromatography market between 2019 and 2030.In order to facilitate the entire process of development of drugs, companies like Merck, Genentech and AstraZeneca have initiated cooperative efforts with institutions like University of Washington Department of Health Sciences, University of Washington Department of Medicine and others. The use of novel techniques like membrane chromatography plays a vital role in drug development, which is anticipated to further prosper in the coming years. Major Key Players of the Membrane Chromatography Market are: Sartorius, GE Healthcare, Asahi Kasei, Danaher, Merck Millipore, Thermo F...

Increasing awareness among patients, technological advancements in the sector of aesthetic treatment of pigmentation related conditions, and growing geriatric population have been pivotal in dictating the growth of the hypopigmentation disorders treatment market. Moreover, increasing incidences of disorders related to hypopigmentation, namely albinism, and vitiligo is anticipated to be the major driver of the global hypopigmentation disorders treatment market between 2019 and 2030. Major Key Players of the Hypopigmentation Disorders Treatment Market are: ALLERGAN, SkinCeuticals International, PIERRE FABRE GROUP, Episciences, RXi Pharmaceuticals, Obagi Cosmeceuticals, and Alvogen among others Read More @  https://www.medgadget.com/2020/09/hypopigmentation-disorders-treatment-market-size-competitive-strategies-application-analysis-regional-and-forecasts-2019-to-2030.html Increasing Incidences of Vitiligo According to the American Academy of Dermatology, vitiligo is considered to...

Strong product pipeline are anticipated to impact the industrial growth over the forecast period of 2019–2030. The novel products are designed to help in development of DNA targeting, with improved flexibility, specificity of nuclease, and the ease of Adeno-Associate Virus (AAV) packaging for delivery. Moreover, utilization of the technique through a number of methods such as disruption of viral DNA, correction in the toxic mutations, or the addition of therapeutic transgenes is projected to boost the adoption. The Genome Editing/Genome Engineering Market is segmented on the basis of Technology, Applications, End Users and region. Major Technology of Genome Editing/Genome Engineering Market covered are: CRISPR TALEN ZFN Major Applications of Genome Editing/Genome Engineering Market covered are: Cell Line Engineering Genetic Engineering Major End Users of Genome Editing/Genome Engineering Market covered are: Research Centers Pharmaceutical & Biotechnology Companies CROs Application ...

Robot-assisted orthopedic surgeries make it possible to accomplish several orthopedic surgical procedures with high level of precision. Orthopedic robotic systems are used for replacement surgeries such as partial or complete knee replacement, and total hip replacement among others, by means of minimally-invasive procedures. Thereby, offering a wide array of benefits which otherwise would result in complications via traditional human-assisted surgeries. Major Key Players of the Orthopedic Surgical Robots Market are: Surgical, SYK CORP (Stryker Corporation), Smith & Nephew, Mazor Robotics (Medtronic), Globus Surgical Inc., DePuy Synthes (Johnson & Johnson Services, Inc.), NuVasive, Inc., Zimmer Biomet and other prominent players. Read More @  https://www.medgadget.com/2020/09/orthopedic-surgical-robots-market-segmentation-application-technology-and-market-analysis-research-report-to-2030-key-players-smith-nephew-mazor-robotics-globus-surgical.html The considerable growth of ...

The rising prevalence of several orthopedic diseases, increasing technological advancements and the growing aging population has augmented the market growth of   knee arthroplasty   globally. The increasing prevalence of osteoarthritis will further contribute to this market growth. Osteoarthritis is one of the most common reasons for knee replacement surgeries globally. According to the Canadian Institute for Health Information, approximately 70,000 knee replacements were performed in Canada in 2017–2018. It is also estimated that the number of patients undergoing joint replacements surgeries would drastically increase in the coming years. Some of the prominent players in the global knee arthroplasty market include: Zimmer Biomet, Stryker, B. Braun Melsungen AG, DePuy Synthes, Integra LifeSciences Corporation, Corin, Allegra, Arthrex, Inc, Exactech, Inc., and Wright Medical Group N.V., among others. Read More @  https://www.medgadget.com/2020/09/knee-arthroplasty-market-s...